KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $0.397 $0.397 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $0.370 $0.400
52 weeks $0.230 $2.03

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Dec 18, 2020 $4.86 $4.88 $4.63 $4.64 326 328
Dec 17, 2020 $4.73 $4.80 $4.70 $4.80 150 540
Dec 16, 2020 $4.66 $4.78 $4.58 $4.72 200 945
Dec 15, 2020 $4.72 $4.74 $4.56 $4.65 192 769
Dec 14, 2020 $4.74 $4.88 $4.56 $4.63 288 553
Dec 11, 2020 $4.22 $4.68 $4.20 $4.67 421 696
Dec 10, 2020 $4.26 $4.35 $4.09 $4.18 657 269
Dec 09, 2020 $4.51 $4.51 $4.21 $4.28 263 416
Dec 08, 2020 $4.55 $4.60 $4.41 $4.45 259 193
Dec 07, 2020 $4.76 $4.79 $4.50 $4.55 344 573
Dec 04, 2020 $4.73 $4.90 $4.65 $4.69 287 507
Dec 03, 2020 $5.17 $5.17 $4.63 $4.67 628 142
Dec 02, 2020 $4.90 $5.25 $4.85 $5.00 1 361 176
Dec 01, 2020 $4.41 $4.97 $4.39 $4.82 703 446
Nov 30, 2020 $4.36 $4.47 $4.24 $4.44 270 627
Nov 27, 2020 $4.29 $4.38 $4.27 $4.34 274 459
Nov 25, 2020 $4.35 $4.35 $4.22 $4.30 171 908
Nov 24, 2020 $4.33 $4.39 $4.18 $4.33 300 271
Nov 23, 2020 $4.15 $4.42 $4.06 $4.28 450 479
Nov 20, 2020 $4.05 $4.10 $3.88 $3.99 535 153
Nov 19, 2020 $4.29 $4.32 $4.03 $4.05 543 151
Nov 18, 2020 $4.39 $4.49 $4.26 $4.31 310 962
Nov 17, 2020 $4.87 $4.91 $4.27 $4.33 1 202 061
Nov 16, 2020 $5.07 $5.09 $4.82 $4.93 200 214
Nov 13, 2020 $5.22 $5.22 $4.92 $4.96 227 048
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT